NOTHING IS REAL! EXAM 1 REVIEW Flashcards

1
Q

Antigens are recognized with high affinity by antibodies because

A

the sequences of three hypervariable loops are selected in an immune response to exquisitely complement the 3D shape of the antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

kcat is what type of parameter?

A

Kinetic rate constant independent of enzyme or substrate concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Change in Km

A

noncompetitive (mixed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Change in Km and Vmax

A

uncompetitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

change Vmax

A

competitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The assigned reading “Therapeutic monoclonal antibodies,” describes several types of engineered antibody molecules that have been developed for therapeutics. Which of the names below DOES refer to a type of therapeutic monoclonal antibody?

A

Fab, BiTE, scFv

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Twelve domains compose an IgG molecule. Of these domains,

A

all have two or more cysteine residues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ig chains

A

4: 2 heavy 2 light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ig fold (Domain)

A

-sandwich of 2 antiparallel B-sheets
-disulfide bond linkage
-hydrophobic residues
-connected to each other by loops = flexible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Substrate enzyme interactions

A

-hydrophobic to hydrophobic
-H bonding
-coloumbic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

KI

A

-dissociation constant
-analogous to KD
-low=more affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cheng-Prusoff

A

relationship btw Ki and IC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The development of an allosteric drug is attractive because

A

it is possible to consider ACTIVATING an enzyme target in treating a disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Darunavir

A

interacts with polypeptide backbone and catalytic asp residues from each subunit of HIV protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The basis for selectivity of certain NSAIDS, such as celecoxib, for COX-2 over COX-1 is

A

the spatial complementarity between the inhibitor and COX-1 is poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIV protease

A

-homodimer
-heme group
-aspartic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aspirin vs everything else on COX

A

acetylates SERINE residue near active site to block access

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mech-based inhibitors

A

-2-thioxanthines on MPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TX2 on MPO

A

covalently bonded to heme via thioether bond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

NSAIDs

A

block prostaglandin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

COX-2 vs COX-1

A

small Valine residue
steric hinderance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Allosteric inhibitor kinetics

A

typically mixed

23
Q

Allosteric inhibition

A

increase Km

24
Q

Cytochrome inhibitor

A

-increase bioavailability/plasma levels of drug
-drug more potent

25
CYP3A4
-monoxygenase -membrane bound -activity and dosing of drugs
26
cytochrome catalytic activity
-insertion of OH from O2 -metabolism of fatty acids -produce vitamin A and D -detoxification
27
G is positive
NEED energy
28
SLC transporters
-large family -most bio substrates -NO energy
29
electrochemical transporters
-SLC (uni,sym,antiport)
30
SLC2
-glucose by uniport
31
SGLT (SLC5)
Na+/glucose -Na+ provides energy to move glucose across gradient -SYMPORT
32
ATP hydrolysis
-P-type (Na/K+ ATPase) -ABC
33
ABC
-energy -lipids -P-glycoprotein
34
P-glycoprotein
hydrolysis of ATP drives NBDs apart and converts TMDs back
35
The A-form DNA helix
often occurs in formation of DNA-RNA hybrid helix.
36
B-DNA
-longer -skinnier -smaller diameter -C'2 endo -bigger pitch and twist
37
B-form major groove
wider and shallower -highly accessible
38
Intercalators
-mod DNA locally -mutagens -stretch base pairs apart -TOTO -small molecules in mostly minor grooves
39
positive supercoiling
-left -overwound -hard to unwind good for bad condititons
40
topologically strained DNA
greater activity for transcription etc
41
TOP 1
1. cuts one strand 2. controlled rotation 3. re-ligate -NO ENERGY -REMOVES supercoiling
42
TOP 2
1. Cuts both strands 2. Moves other strand through opening in cut strand 3. re-ligate -LK change by 2 -gyrase (adds negative) -NEEDS ENERGY
43
TOP inhibitors
-trap complex of enzyme + DNA -inhibit re-ligation -topotecan and irinotecan
44
Nucleosome
DNA wrapped around histone octamer
45
Energy required to deform DNA
from electrostatic interactions between DNA backbone and histone side chains
46
HTH
-2 helices w short turn -second helix binds major groove -first helix stabilizes
47
Zinc Fingers
-a-helix binds -ALSO recognizes RNA -4 cys or 2 cys+2his -tandem
48
bZIP
-leucine every 7th a-helix -dimers -arg and lys basic region binds major groove -phosphate baxkbone and H bonding
49
HLH
-2 a-helix connected by loop -4helix dimer -extension of one a-helix binds major groove
50
CREB domains
-DBD (bzip): binding -Activation domain (Q1 and2): interact with TFs -protein interaction domain (KID): histone acetyltransferases
51
TBP TATA binding protein
B-sheet -MINOR GROOVE -bends TATA box -binding directs assembly of initiation complex
52
Steroid nuclear receptors
-bind steroid then bind to DNA to activate transcription -DBD-hinge-LBD
53